Cannabis Investing Network

Welcome to 2022! As we ring in the new year we look forward and shares some of our predictions of what is to come this year.

We discuss upcoming catalysts to get excited about, headwinds to be cautious about and discuss potential wild cards that could upend the market.

If 2021 taught us anything it was that "Nobody Knows" and "Expect Volatility Ahead".

PS - as we start a new year we are looking to hear your suggestions for what topics you'd like to hear about! Please email us your thoughts

Recapping the rollercoaster of the year that was 2021. Cannabis investors were hoping 2021 would be “The Chosen Year” with potential for significant federal change in the US. Instead we got whiplash and a lesson in humility.

In this episode we rewind to the start of the year and discuss how key events played out. The end of the year is a great time to do some sober reflection on what we got right, what we got wrong and what lessons we can take to (hopefully) improve our game in the future.

Some Key Topics:

- Nobody Knows: the importance of humility and staying nimble

- Everyone is Retail: how price action drives investor mentality

- The Quiet Role of Short Sellers and their impact on cannabis

- Increased Competition across key markets

- SAFE Banking and betting on federal change

We also discuss how the industry has evolved in 2021 and how we are thinking about our investments heading into next year.

Thank you to everyone for listening and sending in great questions! We will see you all in 2022

In this episode we are joined by special guest Hirsh Jain.  Hirsh is the founder of Ananda Strategy, a consultancy that works with many of California's leading cannabis brands and retailers and has helped its clients operationalize some of the most successful cannabis facilities in the state.

We unpack what’s changed since Hirsh’s last appearance.  We address the elephant in the room which is the carnage that’s happening to California operators and why the top MSO’s have shifted their posture to a wait and see strategy vs looking to establish a footprint in the golden state.  Although there is no optimistic sheen to put on California, there are certain steps the companies and municipalities are taking to defend the industry as well as attract investments.  During the second half of the episode, we look at what new states could learn from California to make their regulated cannabis roll out more efficient.

As always, if you have any questions for our guest Hirsh, please reach out to him at  [email protected] or any questions for us please email us.

Connect with Hirsh:

In this episode we are joined by Jarrett Annenberg of Newlake Capital Partners. NLCP is a new OTC listed public cannabis REIT who owns dispensaries and cultivation facilities across the US. Their largest tenants include Curaleaf, Cresco, Trulieve, Columbia Care and other single and multi-state operators.

We touch on a wide variety of topics including:

- Why a delayed SAFE banking will help Newlake grow its portfolio

- History repeating itself: how expectations of SAFE in 2019 are similar to 2021

- The $3B capital opportunity and where Sale-Leaseback fits into the equation

- Origins of Newlake: how the company got started by raising $90M in 2019

- Scaling up by merging with Green Acreage REIT

- How NLCP raised $100M to go public in a soft equity market

- "A Safer Way to Play Cannabis" - why larger investors liked cannabis REITs

- Why investors should be excited about NLCP and its opportunity for capital appreciation

Thanks to Jarrett for joining us!

Jarrett on LinkedIn - https://www.linkedin.com/in/jarrett-annenberg-8584474/

Newlake Investor Deck - https://ir.newlake.com/company-information/presentations

In this episode we are joined by Alan "The Maven" Brochstein. Alan is an extremely experienced cannabis analyst who has been covering the sector since 2014. He is co-founder of New Cannabis Ventures and founder of 420investor. 

In this wide ranging conversation we discuss many different topics including:

- State of the market: how AB sees the cannabis stock action compared to previous years

- Cyclicality of Cannabis Stocks: How the pendulum swings to the extremes

- Staying flexible: the importance of combining trading and investing mentality

- Altria & Cronos: Why Alan thought (and still thinks) Altria should buy Cronos

- Interesting opportunities in the market right now, especially with newer issues

Thanks as always to Alan for joining us to share his insights

Connect with Alan:

Twitter - https://twitter.com/Invest420

In this mega-episode our good friend Nick Gastevich joins us for the Q3 2021 quarterly review of Cresco, Curaleaf, Trulieve, Green Thumb, and Verano (in that order).

We do a deep dive into profitability, cash flow, brands, valuation and how we see the strengths and weaknesses of each company.

We discuss how well positioned each of these companies is for the current phase of our industry and for the future post-uplisting.

Thanks to Nick for another great and extensive review

Connect with Nick:

Twitter - https://twitter.com/CannaVestments

LinkedIn - https://www.linkedin.com/in/nicholas-gastevich-75841346/

Family Office Website - https://www.vginvests.com/ 

What a difference 2 weeks makes!

In this episode we discuss a few key themes around the biggest issues we are seeing in today's market

1) Narratives vs Reality - how the divergence creates opportunity for investors

2) Nancy Mace Legalization bill - what this really means and the effect its having on the market

3) $MSOS huge cash inflows and how we expect this to impact the cannabis stock market short term

4) Strategy - ideas on position your portfolio to play the ups and downs of cannabis volatility

In this episode (which was recorded on Fri Nov 5th) we discuss the rapid sentiment shift from "Depression" to "Euphoria" and why it is an excellent real-time example of the inefficiency of the cannabis investing market.

We often discuss how our market behaves irrationally but in this episode we delve into the reasons why it is that way, examples of irrational behaviour and strategies to take advantage of these swings.

This week we are joined by fan-favourite Nick Gastevich (aka CannaVestments). Nick is an OG cannabis investor whose family office invested in GTI's first round in 2014 (and again in subsequent years). 

In this episode we discuss:

- General negativity in the cannabis sector

- Schumer, SAFE, NDAA and federal politics

- Q3 financial softness in key markets of PA/FL

- Other headwinds which can make the short term choppy

- Positive catalysts being overlooked including potential 2022 legalization in PA/OH/MD/MO/AK

- Re-allocating your portfolio to account for tax loss harvesting

- Owning smaller companies vs the biggest MSOs

- Strategizing for SAFE vs no-SAFE banking

Thanks to Nick for a great episode as usual. 

Connect with Nick:

LinkedIn - https://www.linkedin.com/in/nicholas-gastevich-75841346/

Twitter - https://twitter.com/CannaVestments

Family Office Website - https://www.vginvests.com/

In this (slightly late) episode we debrief a phenomenal MJ Biz conference including our takeaways, the negatives, the positives and our strategies for the coming quarters.

JP October SAFE/NDAA Update - https://www.reddit.com/r/weedstocks/comments/qc4h27/understanding_washington_october_updates/